Lv61
2560 积分 2025-04-08 加入
A Multicenter, Randomized, Double-blinded, Placebo-Controlled Phase III Trial to Evaluate Efficacy and Safety of Picankibart in Moderate-to-Severe Plaque Psoriasis
4个月前
已完结
Early detection of comorbidity in psoriasis: recommendations of the National Conference on Healthcare in Psoriasis
5个月前
已完结
Psoriasis management tree based on comorbidity
5个月前
已完结
Efficacy and Safety of Switching to Picankibart from Non-interleukin-23 Subunit p19 Inhibitors in Patients with Plaque Psoriasis: A Multicenter, Open-Label, Phase 2 Trial
6个月前
已完结
Denifanstat for moderate‐to‐severe acne: A Phase 2, randomized, double‐blind, placebo‐controlled trial
8个月前
已完结
Secukinumab retreatment-as-needed versus fixed-interval maintenance regimen for moderate to severe plaque psoriasis: A randomized, double-blind, noninferiority trial (SCULPTURE)
9个月前
已完结
Psoriasis
1年前
已完结
皖公网安备34019202002308
